Effect of blockade of the EGF system on wound healing in patients vaccinated with CIMAvax® EGF

World Journal of Surgical Oncology

Volumn 11, Issue , 2013, Pages

  Fernández Lorente, Aymara ^a   Acosta Brooks, Soraida ^b   Neninger Vinageras, Elia ^c   Barroso Alvarez, María D C ^a   Wilkinson Brito, Barbara ^a   Troche Concepción, Mayelin ^a   Martínez Pérez, Liana B ^a   Viada González, Carmen E ^a   Crespo Diaz, Tatiana ^d   Casacó Parada, Angel R ^a  

^a CENTER OF MOLECULAR IMMUNOLOGY   (Cuba)

^b Saturnino Lora University Hospital   (Cuba)

^c HOSPITAL CLINICOQUIRÚRGICO HERMANOS AMEIJEIRAS   (Cuba)

^d Hospital Neumologico Benefico Juridico   (Cuba)

Author keywords

CIMAvax EGF; EGF; EGFR; Wound healing

Indexed keywords

CANCER VACCINE; CIMAVAX; CISPLATIN; CYCLOPHOSPHAMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; NIMOTUZUMAB; UNCLASSIFIED DRUG; VINBLASTINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER IMMUNIZATION; CANCER SURGERY; CHRONIC GASTRITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CRANIOTOMY; DETERIORATION; DRUG EFFECT; FEMALE; HERNIOPLASTY; HUMAN; HUMAN TISSUE; INGUINAL HERNIA; LARYNGECTOMY; LARYNX PAPILLOMATOSIS; LARYNX SQUAMOUS CELL CARCINOMA; LOBECTOMY; LUNG ADENOCARCINOMA; LUNG EMPHYSEMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; MEDICAL RECORD REVIEW; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NATIONAL HEALTH ORGANIZATION; PLEURA EFFUSION; RETROSPECTIVE STUDY; SKIN INJURY; THORACOTOMY; TUMOR BIOPSY; WOUND HEALING;

AGED; CANCER VACCINES; CARCINOMA, NON-SMALL-CELL LUNG; EPIDERMAL GROWTH FACTOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 84885356388     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-11-275     Document Type: Article

References (33)

1. Wong AJ, Ruppert JM, Bigner SH. Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc Natl Acad Sci USA 1992, 89:2965-2969. 10.1073/pnas.89.7.2965, 48784, 1557402.
2. Damstrup L, Kuwada SK, Dempsey PJ. Amphiregulin acts as an autocrine growth factor in two human polarizing colon cancer lines that exhibit domain selective EGF receptor mitogenesis. Br J Cancer 1999, 80:1012-1019. 10.1038/sj.bjc.6690456, 2363033, 10362109.
3. Peghini PL, Iwamoto M, Raffeld M. Overexpression of epidermal growth factor and hepatocyte growth factor receptors in a proportion of gastrinomas correlates with aggressive growth and lower curability. Clin Cancer Res 2002, 8:2273-2285.
4. Arteaga CL. The epidermal growth factor receptor: from mutant oncogene in nonhuman cancers to therapeutic target in human neoplasia. J Clin Oncol 2001, 19:32-40.
5. Mendelsohn J, Baselga J. Epidermal growth factor receptor targeting in cancer. Semin Oncol 2006, 33:369-385. 10.1053/j.seminoncol.2006.04.003, 16890793.
6. Greenhalgh DG. The role of growth factors in wound healing. J Trauma 1996, 41:159-167. 10.1097/00005373-199607000-00029, 8676414.
7. Schultz GS, White M, Mitchell R, Brown G, Lynch J, Twardzik DR, Todaro GJ. Epithelial wound healing enhanced by transforming growth factor- and vaccinia- growth factor. Science 1987, 235:350-352. 10.1126/science.3492044, 3492044.
8. Steed DL. Modifying the wound healing response with exogenous growth factors. Clin Plast Surg 1998, 25:397-405.
9. Repertinger SK, Campagnaro E, Fuhrman J, El-Abaseri T, Yuspa SH, Hansen LA. EGFR enhances early healing after cutaneous incisional wounding. J Invest Dermatol 2004, 123:982-989. 10.1111/j.0022-202X.2004.23478.x, 15482488.
10. Neninger E, de la Torre A, Osorio M, Catalá M, Bravo I, Mendoza M, Abreu D, Acosta S, Rives R, Carrillo C, Gonzalez M, Viada C, García B, Crombet T, Gonzalez G, Lage A. Phase II randomized controlled trial of an epidermal growth factor vaccine in advanced non-small-cell lung cancer. J Clin Onc 2008, 26(9):1452-1458.
11. Gonzalez G, Crombet T, Torres F, Catalá M, Alfonso L, Osorio M, Neninger E, Garcia B, Mulet A, Perez R, Lage A. Epidermal growth factor-based cancer vaccine for non-small-cell lung cancer therapy. Ann Oncol 2003, 14(3):461-466. 10.1093/annonc/mdg102, 12598354.
12. Crombet T, Neninger E, Catalá M, García B, Leonard I, Gonzalez G, Pérez R, Lage A. Treatment of NSCLC patients with an EGF-based cancer vaccine: report of a phase I trial. Cancer Biol Ther 2006, 5(2):145-149. 10.4161/cbt.5.2.2334, 16357522.
13. García B, Neninger E, de la Torre A, Leonard I, Martínez R, Viada C, González G, Mazorra Z, Lage A, Crombet T. Effective inhibition of the epidermal growth factor/epidermal growth factor receptor binding by anti-epidermal growth factor antibodies is related to better survival in advanced non-small-cell lung cancer patients treated with the epidermal growth factor cancer vaccine. Clin Cancer Res 2008, 14(3):840-846. 10.1158/1078-0432.CCR-07-1050, 18245547.
14. González G, Lage A, Crombet T, Rodríguez G, García B, Cuevas A, Viña L, Arteaga N, Neninger E. CIMAvax®-EGF: a novel therapeutic vaccine for advanced lung cancer. Biotecnol Apl 2009, 26(4).
15. Gonzalez G, Crombet T, Lage A. Chronic vaccination with a therapeutic EGF-based cancer vaccine: a review of patients receiving long lasting treatment. Curr Cancer Drug Targets 2011, 11(1):103-110. 10.2174/156800911793743583, 21062240.
16. Guillen G, Silva R, Alvarez A, Coizeau E, Novoa L, Selman M, Morales J, Musacchio A, del Valle J, Delgado M, Tamayo B, Caballero E, Fernandez JR, Herrera L, et al. Cloning and expression of a high molecular weight protein (PM-6) from the Neisseria meningitidis strain B: 4PL15. Evaluation of the immunogenicity and bacterial activity of antibodies raised against the recombinant protein. Pathology and Immunobiology of Neisseriaceae 1994, 834-840. Cuernavaca, Mexico: National Institute of Public Health, Conde-Gonzalez CJ, Morse S, Rice P.
17. Silva R, Selman R, Guillén G, Herrera L, Fernandez JR, Novoa L, Morales J, Moreira V, González S, Tamargo B, del Valle JA, Caballero E, Alvarez A, Coizeau E, Cruz S, Musacchio A. Nucleotide sequence coding for an outer membrane protein from Neisseria meningitidis and use of said sequence in vaccine preparations. USA patent 1994, 5:286-484.
18. Rodríguez G, Albisa A, Viña L, Cuevas A, García B, García AT, Portillo A, Calvo L, Crombet T, González G, Chico E. Manufacturing process development for an epidermal growth factor-based cancer vaccine. Int Biopharm. 2008, 21:2-8.
19. Vacuna Cubana Contra el Cáncer de Pulmón Avanzado Llega a Otros Países 2012, http://www.docsalud.com/articulo/2946/vacuna-cubana-contra-el-c%C3%A1ncer-depulm%C3%B3n-avanzado-llega-a-otros-pa%C3%ADses. Accessed December 28, 2012.
20. González G, Crombet T, Catalá M, Mirabal V, Hernández JC, González Y, Marinello P, Guillén G, Lage A. A novel vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: report of a pilot clinical trial. Ann Oncol 1998, 9:431-435. 10.1023/A:1008261031034, 9636835.
21. González G, Crombet T, Neninger E, Viada C, Lage A. Therapeutic vaccination with epidermal growth factor (EGF) in advanced lung cancer. Analysis of pooled data from three clinical trials. Human Vacc. 2007, 3:8-13.
22. Neninger E, García B, Crombet T, Viada C, Pereda S, Leonard I, Mazorra Z, Fleites G, González M, Wilkinson B, González G, Lage A. Combining an EGF-based cancer vaccine with chemotherapy in advanced non-small cell lung cancer. J Immunol 2009, 32:92-99.
23. Gabriel A, Mussman J, Rosenberg LZ, de la Torre JI. Wound healing, growth factors 2009, 1-11. University School of Medicine.
24. Thomas C. Checklist for factors affecting wound healing. Adv Skin Wound Care 2011, 24(4):192. 10.1097/01.ASW.0000396300.04173.ec, 21422844.
25. Cortes J, Caralt M, Delaloge S, Cortes-Funes H, Pierga JY. Safety of bevacizumab in metastatic breast cancer patients undergoing surgery. Eur J Cancer 2012, 48(4):475-481. 10.1016/j.ejca.2011.11.021, 22196033.
26. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen 2008, 16:585-601. 10.1111/j.1524-475X.2008.00410.x, 19128254.
27. Rodriguez G, Gonzalez G, Crombet T, Lage A. Therapeutic vaccination with an EGF-based vaccine in lung cancer: a step in the transition to a chronic disease. Expert Rev Respir Med 2011, 5:337-342. 10.1586/ers.11.12, 21702656.
28. Casacó A, Díaz Y, Ledón N, Merino N, Valdés O, Garcia G, Garcia B, González G, Pérez R. Effect of an egf-cancer vaccine on wound healing and inflammation models. J Surg Res 2004, 122:130-134. 10.1016/j.jss.2004.06.008, 15522325.
29. Mellor J, Cassumbhoy M, Jefford M. Clinical guidance on the perioperative use of targeted agents in solid tumor oncology. J Clin Oncol 2011, 7:106-113.
30. Casacó A, Fuente D, Ledón N, Fernández A, Crombet T. Anti-epidermal growth factor/epidermal growth factor receptor therapeutic anti-cancer drugs and the wound healing process. J Cancer Sci Ther 2012, 4:324-329.
31. Zieske JD, Takahashi H, Hutcheon AE, Dalbone AC. Activation of epidermal growth factor receptor during corneal epithelial migration. Invest Ophthalmol Vis Sci 2000, 41:1346.
32. Bennett N, Schultz G. Growth factors and wound healing: biochemical properties of growth factors and their receptors. Am J Surg 1993, 165:728. 10.1016/S0002-9610(05)80797-4, 8506974.
33. Wells A. EGF receptor. Int J Biochem Cell Biol 1999, 31:637. 10.1016/S1357-2725(99)00015-1, 10404636.